Abnormal olfactory function demonstrated by manganese-enhanced MRI in mice with experimental neuropsychiatric lupus: Annals of the New York Academy of Sciences

Annals of the New York Academy of Sciences

Volumn 1193, Issue , 2010, Pages 70-77

  Kivity, Shaye ^a   Tsarfaty, Galia ^a   Agmon Levin, Nancy ^a   Blank, Miri ^a   Manor, David ^a   Konen, Eli ^a   Chapman, Joab ^a,c   Reichlin, Morris ^b   Wasson, Craig ^b   Shoenfeld, Yehuda ^a,c   Kushnir, Tammar ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Autoantibodies; Lupus; Magnetic resonance imaging; Psychology; Systemic lupus erythematous

Indexed keywords

ANTIBODY; ANTIRIBOSOMAL PHOSPHORPROTEIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; MANGANESE; MENTHOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIMMING TEST; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTORY SYSTEM; PASSIVE IMMUNIZATION; RIGHT HEMISPHERE; SMELLING; SMELLING DISORDER; SYSTEMIC LUPUS ERYTHEMATOSUS;

MUS;

EID: 77951238389     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05302.x     Document Type: Conference Paper

References (46)

1. Borchers,A.T., C.A.Aoki, S.M.Naguwa, et al. 2005.Neuropsychiatric features of systemic lupus erythematosus. Autoimmun. Rev. 4: 329-344.
2. Stojanovich, L., G. Zandman-Goddard, S. Pavlovich & N. Sikanich. 2007. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun. Rev. 6: 421-426.
3. Hanly, J.G., N.M. Walsh & V. Sangalang. 1992. Brain pathology in systemic lupus erythematosus. J. Rheumatol. 19: 732-741.
4. Bonfa, E., S.J. Golombek, L.D. Kaufman, et al. 1987. Association between lupus psychosis and anti-ribosomal P protein antibodies. N. Engl. J. Med. 317: 265-271.
5. Toubi, E. & Y. Shoenfeld. 2007. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun. Rev. 6: 119-125.
6. Arnett, F.C., J.D. Reveille, H.M. Moutsopoulos, et al. 1996. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetic associations. Arthritis Rheum. 39: 1833-1839.
7. Schneebaum, A.B., J.D. Singleton, S.G.West, et al. 1991. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am. J. Med. 90: 54-62.
8. Katzav, A., I. Solodeev,O. Brodsky, et al. 2007. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum. 56: 938-948.
9. Katzav, A., T. Ben-Ziv, J. Chapman, et al. 2008. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression). J. Autoimmun. 31: 393-398.
10. Shoenfeld, N., N. Agmon-Levin, I. Flitman-Katzevman, et al. 2009. The sense of smell in systemic lupus erythematosus. Arthritis Rheum. 60: 1484-1487.
11. Emmer, B.J., J. van der Grond, G.M. Steup-Beekman, et al. 2006. Selective involvement of the amygdala in systemic lupus erythematosus. PLoSMed. 3: 2285-2290.
12. Appenzeller, S., A.D. Carnevalle, L.M. Li, et al. 2006. Hippocampal atrophy in systemic lupus erythematosus. Ann. Rheum. Dis. 65: 1585-1589.
13. Narita, K., F. Kawasaki & H. Kita. 1990. Mn and Mg influxes through Ca channels of motor nerve terminals are prevented by verapamil in frogs. Brain Res. 510: 289-295.
14. Pautler, R.G., A.C. Silva & A.P. Koretsky. 1998. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn. Reson. Med. 40: 740-748.
15. Tjalve, H., J. Henriksson, J. Tallkvist, et al. 1996. Uptake of manganese and cadmium from the nasal mucosa into the central nervous systemvia olfactory pathways in rats. Pharmacol. Toxicol. 79: 347-356.
16. Tjalve, H., C. Mejare & K. Borg-Neczak. 1995. Uptake and transport of manganese in primary and secondary olfactory neurones in pike. Pharmacol. Toxicol. 77: 23-31.
17. Watanabe, T., T.Michaelis & J. Frahm. 2001.Mapping of retinal projections in the living rat using high-resolution 3D gradient-echo MRI with Mn2+-induced contrast. Magn. Reson. Med. 46: 424-429.
18. Thuen, M., T.E. Singstad, T.B. Pedersen, et al. 2005. Manganese-enhanced MRI of the optic visual pathway and optic nerve injury in adult rats. J. Magn. Reson. Imaging 22: 492-500.
19. Cross,D.J., S.Minoshima, Y. Anzai, et al. 2004. Statistical mapping of functional olfactory connections of the rat brain in vivo. Neuroimage 23: 1326-1335.
20. Koscec, M., E. Koren, M. Wolfson-Reichlin, et al. 1997. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J. Immunol. 159: 2033-2041.
21. Shoenfeld, Y., A. Nahum, A.D. Korczyn, et al. 2003. Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12: 436-442.
22. Porsolt, R.D., A. Bertin & M. Jalfre. 1977. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229: 327-336.
23. Becker,M., V. Lavie & B. Solomon. 2007. Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenicmouse model ofAlzheimer's disease. Proc. Natl. Acad. Sci. USA 104: 1691-1696.
24. Paxinos, G. & K.B.J. Franklin. 2001. The Mouse Brain in Stereotaxic Coordinates. 2nd edn. Academic Press. San Diego, CA.
25. Rorden, C. MRIcron, version Beta of September 6, 2007. Available at www.mricro.com.
26. Chuang, K.H. & A.P. Koretsky. 2009. Accounting for nonspecific enhancement in neuronal tract tracing using manganese enhanced magnetic resonance imaging. Magn. Reson. Imaging 27: 594-600.
27. Small, D.M., M.G. Veldhuizen, J. Felsted, et al. 2008. Separable substrates for anticipatory and consummatory food chemosensation. Neuron 57: 786-797.
28. Vosshall, L.B. 2005. Social signals: the secret language of mice. Curr. Biol. 15: R255-R257.
29. Bear, D.M. 1983. Hemispheric specialization and the neurology of emotion. Arch. Neurol. 40: 195-202.
30. Eslinger, P.J., A.R. Damasio & G.W. Van Hoesen. 1982. Olfactory dysfunction in man: anatomical and behavioral aspects. Brain Cogn. 1: 259-285.
31. Engen, T. 1988. The acquisition of odour hedonics. In Perfumery: The Psychology and Biology of Fragrance. S. Van Toller & G.H. Dodd, Eds.: 79-90. Chapman & Hall. London.
32. Kopala, L.C., C. Clark & T. Hurwitz. 1993. Olfactory deficits in neuroleptic naive patients with schizophrenia. Schizophr. Res. 8: 245-250.
33. Ponsen,M.M.,D. Stoffers, J. Booij, et al. 2004. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann. Neurol. 56: 173-181.
34. Daniel, S.E. & C.H. Hawkes. 1992. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 340: 186.
35. Morgan, C.D., S.Nordin & C.Murphy. 1995. Odor identification as an early marker for Alzheimer's disease: impact of lexical functioning and detection sensitivity. J. Clin. Exp. Neuropsychol. 17: 793-803.
36. Zueger,M., A. Urani, S. Chourbaji, et al. 2005. Olfactory bulbectomy in mice induces alterations in exploratory behavior. Neurosci. Lett. 374: 142-146.
37. Satoh, S., N. Morita, I. Matsuzaki, et al. 1996. Relationship between odor perception and depression in the Japanese elderly. Psychiatry Clin. Neurosci. 50: 271-275.
38. T. Komori, R. Fujiwara, M. Tanida & J. Nomura. 1995. Potential antidepressant effects of lemon odor in rats. Eur. Neuropsychopharmacol. 5: 477-480.
39. Komori, T. et al. 1995. Effects of citrus fragrance on immune function and depressive states. Neuroimmunomodulation 2: 174-180.
40. Kelly, J.P., A.S. Wrynn & B.E. Leonard. 1997. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol. Ther. 74: 299-316.
41. Roche, M., A. Harkin & J.P. Kelly. 2007. Chronic fluoxetine treatment attenuates stressor-induced changes in temperature, heart rate, and neuronal activation in the olfactory bulbectomized rat. Neuropsychopharmacology 32: 1312-1320.
42. Pause, B.M., A. Miranda, R. G̈oder, et al. 2001. Reduced olfactory performance in patientswith major depression. J. Psychiatr. Res. 35: 271-277.
43. Novoselova, E.G., N.V. Bobkova, O.V. Glushkova, et al. 2004. Immunodepressed status of mice after bulbectomy. Izv Akad. Nauk Ser. Biol. 732-739.
44. Breivik, T., Y. Gundersen, T. Myhrer, et al. 2006. Enhanced susceptibility to periodontitis in an animal model of depression: reversed by chronic treatment with the anti-depressant tianeptine. J. Clin. Periodontol. 33: 469-477.
45. Zivadinov, R.,M. Zorzon, L.Monti Bragadin, et al. 1999. Olfactory loss in multiple sclerosis. J. Neurol. Sci. 168: 127-130.
46. Alexander, J.J., L. Bao, A. Jacob, et al. 2003. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis. Biochim. Biophys. Acta. 1639: 169-176.